Skip to Main Content

Paper Details

Genomic, pathological, and clinical heterogeneity as drivers of personalized medicine in prostate cancer.
Urol Oncol
92
2015
Author NameAffiliation
Michael FraserOntario Cancer Institute and Princess Margaret Cancer Center (University Health Network)
Alejandro BerlinOntario Cancer Institute and Princess Margaret Cancer Center (University Health Network), University of Toronto
Robert G BristowOntario Cancer Institute and Princess Margaret Cancer Center (University Health Network), University of Toronto
Theodorus H van der KwastToronto General Hospital (University Health Network)
  • 1 - 4

Datasets